William Blair Predicts Reduced Earnings for Encompass Health

Encompass Health Co. (NYSE:EHC) – Equities research analysts at William Blair decreased their Q1 2025 earnings estimates for shares of Encompass Health in a research note issued on Friday, February 7th. William Blair analyst J. Haase now expects that the company will earn $1.16 per share for the quarter, down from their prior estimate of $1.20. William Blair has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. William Blair also issued estimates for Encompass Health’s Q2 2025 earnings at $1.12 EPS, Q3 2025 earnings at $1.14 EPS, Q4 2025 earnings at $1.32 EPS and FY2026 earnings at $5.39 EPS.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%.

EHC has been the subject of a number of other research reports. KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday. Barclays upped their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday, February 7th. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 0.7 %

Shares of NYSE EHC opened at $99.37 on Monday. The firm’s 50 day moving average price is $96.14 and its 200 day moving average price is $95.41. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $10.01 billion, a P/E ratio of 22.28, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. Encompass Health has a 1 year low of $72.38 and a 1 year high of $104.55.

Hedge Funds Weigh In On Encompass Health

A number of institutional investors have recently added to or reduced their stakes in EHC. MassMutual Private Wealth & Trust FSB increased its holdings in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares during the last quarter. UMB Bank n.a. lifted its position in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC boosted its stake in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in Encompass Health during the third quarter valued at approximately $40,000. Finally, CBIZ Investment Advisory Services LLC grew its holdings in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after acquiring an additional 127 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.